655 related articles for article (PubMed ID: 30768988)
1. Validation of Baveno VI Criteria for Screening and Surveillance of Esophageal Varices in Patients With Compensated Cirrhosis and a Sustained Response to Antiviral Therapy.
Thabut D; Bureau C; Layese R; Bourcier V; Hammouche M; Cagnot C; Marcellin P; Guyader D; Pol S; Larrey D; De Lédinghen V; Ouzan D; Zoulim F; Roulot D; Tran A; Bronowicki JP; Zarski JP; Goria O; Calès P; Péron JM; Alric L; Bourlière M; Mathurin P; Blanc JF; Abergel A; Serfaty L; Mallat A; Grangé JD; Attali P; Bacq Y; Wartelle-Bladou C; Dao T; Pilette C; Silvain C; Christidis C; Capron D; Bernard-Chabert B; Hillaire S; Di Martino V; Sutton A; Audureau E; Roudot-Thoraval F; Nahon P;
Gastroenterology; 2019 Mar; 156(4):997-1009.e5. PubMed ID: 30768988
[TBL] [Abstract][Full Text] [Related]
2. Course of oesophageal varices and performance of noninvasive predictors following Hepatitis C Virus clearance in compensated advanced chronic liver disease.
Giannini EG; De Maria C; Crespi M; Demarzo MG; Fazio V; Grasso A; Torre F; Bodini G; Marabotto E; Furnari M
Eur J Clin Invest; 2020 May; 50(5):e13231. PubMed ID: 32291753
[TBL] [Abstract][Full Text] [Related]
3. Impact of sustained virological response with DAAs on gastroesophageal varices and Baveno criteria in HCV-cirrhotic patients.
Puigvehí M; Londoño MC; Torras X; Lorente S; Vergara M; Morillas RM; Masnou H; Serrano T; Miquel M; Gallego A; Lens S; Carrión JA
J Gastroenterol; 2020 Feb; 55(2):205-216. PubMed ID: 31493238
[TBL] [Abstract][Full Text] [Related]
4. Validation of original, expanded Baveno VI, and stepwise & platelet-MELD criteria to rule out varices needing treatment in compensated cirrhosis from various etiologies.
Nawalerspanya S; Sripongpun P; Chamroonkul N; Kongkamol C; Piratvisuth T
Ann Hepatol; 2020; 19(2):209-213. PubMed ID: 31607647
[TBL] [Abstract][Full Text] [Related]
5. Baveno VI criteria and spleen stiffness measurement rule out high-risk varices in virally suppressed HBV-related cirrhosis.
Wang H; Wen B; Chang X; Wu Q; Wen W; Zhou F; Guo Y; Ji Y; Gu Y; Lai Q; He Q; Li J; Chen J; Hou J
J Hepatol; 2021 Mar; 74(3):584-592. PubMed ID: 33039403
[TBL] [Abstract][Full Text] [Related]
6. Non-invasive prediction of esophageal varices by stiffness and platelet in non-alcoholic fatty liver disease cirrhosis.
Petta S; Sebastiani G; Bugianesi E; Viganò M; Wong VW; Berzigotti A; Fracanzani AL; Anstee QM; Marra F; Barbara M; Calvaruso V; Cammà C; Di Marco V; Craxì A; de Ledinghen V
J Hepatol; 2018 Oct; 69(4):878-885. PubMed ID: 29802949
[TBL] [Abstract][Full Text] [Related]
7. Sustained virologic response prevents the development of esophageal varices in compensated, Child-Pugh class A hepatitis C virus-induced cirrhosis. A 12-year prospective follow-up study.
Bruno S; Crosignani A; Facciotto C; Rossi S; Roffi L; Redaelli A; de Franchis R; Almasio PL; Maisonneuve P
Hepatology; 2010 Jun; 51(6):2069-76. PubMed ID: 20196120
[TBL] [Abstract][Full Text] [Related]
8. Screening and surveillance of oesophageal varices in patients with HCV-positive liver cirrhosis successfully treated by direct-acting antiviral agents.
Ciancio A; Ribaldone DG; Salamone R; Bruno M; Caronna S; Debernardi Venon W; Giordanino C; Mondardini A; Musso A; Pennazio M; Rolle E; Sacco M; Sprujevnik T; De Angelis C; Saracco GM
Liver Int; 2022 May; 42(5):1121-1131. PubMed ID: 35220668
[TBL] [Abstract][Full Text] [Related]
9. A combined model based on spleen stiffness measurement and Baveno VI criteria to rule out high-risk varices in advanced chronic liver disease.
Colecchia A; Ravaioli F; Marasco G; Colli A; Dajti E; Di Biase AR; Bacchi Reggiani ML; Berzigotti A; Pinzani M; Festi D
J Hepatol; 2018 Aug; 69(2):308-317. PubMed ID: 29729368
[TBL] [Abstract][Full Text] [Related]
10. The long-term benefits of nucleos(t)ide analogs in compensated HBV cirrhotic patients with no or small esophageal varices: A 12-year prospective cohort study.
Lampertico P; Invernizzi F; Viganò M; Loglio A; Mangia G; Facchetti F; Primignani M; Jovani M; Iavarone M; Fraquelli M; Casazza G; de Franchis R; Colombo M
J Hepatol; 2015 Nov; 63(5):1118-25. PubMed ID: 26100495
[TBL] [Abstract][Full Text] [Related]
11. Deciding Among Noninvasive Tools for Predicting Varices Needing Treatment in Chronic Liver Disease: An Analysis of Asian Cohort.
Sharma S; Agarwal S; Gunjan D; Kaushal K; Anand A; Saraya A
Am J Gastroenterol; 2020 Oct; 115(10):1650-1656. PubMed ID: 32516202
[TBL] [Abstract][Full Text] [Related]
12. Non-invasive diagnosis of esophageal varices after Baveno VI.
Moctezuma Velázquez C; Abraldes JG
Turk J Gastroenterol; 2017 May; 28(3):159-165. PubMed ID: 28492370
[TBL] [Abstract][Full Text] [Related]
13. Validation of the Baveno VI criteria to identify low risk cirrhotic patients not requiring endoscopic surveillance for varices.
Maurice JB; Brodkin E; Arnold F; Navaratnam A; Paine H; Khawar S; Dhar A; Patch D; O'Beirne J; Mookerjee R; Pinzani M; Tsochatzis E; Westbrook RH
J Hepatol; 2016 Nov; 65(5):899-905. PubMed ID: 27388923
[TBL] [Abstract][Full Text] [Related]
14. RESIST-HCV Criteria to Monitor Progression of Low-Risk Esophageal Varices in Patients With Compensated Cirrhosis After HCV Eradication: The SIMPLE Study: SIMPLE: Scoring Index to Monitor Progression of Low-risk Esophageal varices.
Calvaruso V; Celsa C; D'Ambrosio R; Simone F; Petta S; Cacciola I; Enea M; Battaglia S; Pandolfo A; Licata M; Degasperi E; Cabibbo G; Di Marco L; Pennisi G; Borghi M; Di Martino V; Filomia R; Abdel-Hadi Y; Crapanzano L; Raimondo G; Lampertico P; Craxì A; Cammà C; Di Marco V
Am J Gastroenterol; 2022 Nov; 117(11):1816-1824. PubMed ID: 35973181
[TBL] [Abstract][Full Text] [Related]
15. Baveno VI and Expanded Baveno VI criteria successfully predicts the absence of high-risk gastro-oesophageal varices in a Chilean cohort.
Gaete MI; Díaz LA; Arenas A; González K; Cattaneo M; Fuster F; Henríquez R; Soza A; Arrese M; Barrera F; Arab JP; Benítez C
Liver Int; 2020 Jun; 40(6):1427-1434. PubMed ID: 31916360
[TBL] [Abstract][Full Text] [Related]
16. Validating, deconstructing and refining Baveno criteria for ruling out high-risk varices in patients with compensated cirrhosis.
Jangouk P; Turco L; De Oliveira A; Schepis F; Villa E; Garcia-Tsao G
Liver Int; 2017 Aug; 37(8):1177-1183. PubMed ID: 28160373
[TBL] [Abstract][Full Text] [Related]
17. Is Transient Elastography Needed for Noninvasive Assessment of High-Risk Varices? The REAL Experience.
Calvaruso V; Cacciola I; Licata A; Madonia S; Benigno R; Petta S; Bronte F; Conte E; Malizia G; Bertino G; Distefano M; Montineri A; Digiacomo A; Alaimo G; Cacopardo B; Davì A; Guarneri L; Scalisi I; Colletti P; Cartabellotta F; Portelli V; Prestileo T; Averna A; Iacobello C; Mondello L; Scifo G; Russello M; Squadrito G; Raimondo G; Cammà C; Craxì A; Di Marco V;
Am J Gastroenterol; 2019 Aug; 114(8):1275-1282. PubMed ID: 31135449
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of three "beyond Baveno VI" criteria to safely spare endoscopies in compensated advanced chronic liver disease.
Tosetti G; Primignani M; La Mura V; D'Ambrosio R; Degasperi E; Mezzina N; Viganò M; Rumi M; Fracanzani AL; Lombardi R; Fargion S; Fraquelli M; Aghemo A; Lampertico P
Dig Liver Dis; 2019 Aug; 51(8):1135-1140. PubMed ID: 30691777
[TBL] [Abstract][Full Text] [Related]
19. Liver stiffness and serum markers for excluding high-risk varices in patients who do not meet Baveno VI criteria.
Zhou H; Long J; Hu H; Tian CY; Lin SD
World J Gastroenterol; 2019 Sep; 25(35):5323-5333. PubMed ID: 31558876
[TBL] [Abstract][Full Text] [Related]
20. Validation of the Baveno VI and the expanded Baveno VI criteria to identify patients who could avoid screening endoscopy.
Bae J; Sinn DH; Kang W; Gwak GY; Choi MS; Paik YH; Lee JH; Koh KC; Paik SW
Liver Int; 2018 Aug; 38(8):1442-1448. PubMed ID: 29495113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
